Research is the most potent weapon in our fight against bowel disease. So we’re delighted to announce that this February, we approved funding of £200,000 to 9 new projects. It was the first time we were able to approve funding for all successful applications approved by our peer review process.
The studies are taking place in hospitals and universities across the UK.
They focus on a very broad range of topics, in line with our mission to fund research into bowel diseases of all kinds.
Work in Chester will aim to improve treatment for people hospitalised with diverticular disease – an increasingly common problem that urgently needs attention.
A study in Newcastle will explore the type of bacteria associated with fistulas in Crohn’s disease. This could lead to earlier diagnosis of Crohn’s fistula, and identify new targets for future treatment.
Also in Newcastle is work that brings hope of improved survival rates for people with late stage rectal cancer.
In Coventry, researchers will try to discover whether simple urine and/or stool tests can detect the earliest signs of bowel cancer – potentially enabling surgeons to stop the disease in its tracks.
Different projects in Birmingham and Southampton aim to expand knowledge of how cutting edge immunotherapy could benefit people with bowel cancer.
A study in Sheffield will look at how care pathways for elderly people needing emergency surgery can be improved.
Rounding out the list are two studies in Edinburgh. One aims to explore the relationship between low Vitamin D levels and bowel cancer. The other tests a new method of healing anal fissures, which could offer a cost effective new treatment for this common problem.
Without our supporters’ donations, we wouldn’t have been able to fund these projects. Like many of our past studies they have huge potential to grow into major advances in clinical practice and improving outcomes for patients.
We will endeavor to keep you posted on progress with all of these projects. The easiest way for you to keep abreast of all the latest news from the front line of bowel disease research is to sign up for our monthly e-mail newsletter.